Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.88 USD
Change Today +0.03 / 1.05%
Volume 2.8K
CLRB On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry S. Palmin

Former Chief Executive Officer, President and Director, Cellectar Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Harry S. Palmin serves as Chief Executive Officer and President of Acer Therapeutics Inc. Mr. Palmin served as the Chief Executive Officer and President of Novelos Therapeutics, Inc. (formerly Common Horizons Inc.) from January 2005 to October 4, 2013 and from 1998 to October 4, 2013 respectively. Mr. Palmin served as the Acting Chief Executive Officer of Novelos Therapeutics from 1998 to 2005 and served as its Chief Financial Officer. He served as Vice President, ...

Read Full Background

Corporate Headquarters*

3301 Agriculture Drive
Madison, Wisconsin 53716

United States

Phone: 608-441-8120
Fax: 608-441-8121

Board Members Memberships*

Chief Executive Officer, President, and Director
Former Chief Executive Officer, President and Director
Former Chief Executive Officer, President and Director


Unknown/Other Education
The London School of Economics and Political Science
Unknown/Other Education
Copenhagen Business School
International Business School at Brandeis University
International Business School at Brandeis University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLRB:US $2.88 USD +0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLECTAR BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at